Agents that decrease ROS can suppress taxol-induced cytotoxicity, whereas increase of ROS levels by inhibition of SOD or glutamylcysteine synthase can enhance taxol-induced cytotoxicity in cancer cell lines (Ramanathan et al, 2005). The gene discussed is SOD1; the disease is cancer.